Transplant Patients Need Anti-Rejection Drugs. Why Won’t Insurers Pay for Some of Them?

Drugs to prevent organ rejection are not always covered for patients who had transplants before they enrolled in Medicare. GINA KOLATA https://ift.tt/2CQNI7l https://ift.tt/2FQ0ncu The New York Times Health Transplants, Drugs (Pharmaceuticals) April 2, 2019 at 12:00AM